Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate plus propofol opioid-free anesthesia for painless gastroenteroscopy in older adults
ChiCTR2400093095Phase 4Not yet recruiting
- Sponsor
- Yancheng First People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of magnesium sulfate, propofol and sufentanil in gastrointestinal conditions (2 arms), sponsored by Yancheng First People's Hospital. Primary endpoint: Incidence of respiratory depression. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
magnesium sulfatepropofolsufentanil
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2400093095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093095.